The JAK2 exon 12 mutations: a comprehensive review.

Abstract excerpt

A variety of acquired mutations targeting JAK2 exon 12 are present in those patients with the myeloproliferative neoplasm, polycythemia vera, that lack the more common JAK2V617F mutation. Both mutation types perturb erythropoiesis, with individuals presenting with a raised hematocrit, reduced serum erythropoietin levels, and erythropoietin-independent erythroid progenitor cells. However, there are also phenotypic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Models, Molecular
• Share to Polycythemia Vera
• Share to Exons